Study of the Prevalence and the Incidence of the Prostate Cancer in the North-Cameroon: Means and Costs of Management

Authors

  • Herve Kada Pabame Department of Biomedical Sciences, Faculty of Science, University of Ngaoundere, Ngaoundere, Cameroon
  • Armel Herve Nwabo Kamdje Department of Biomedical Sciences, Faculty of Science, University of Ngaoundere, Ngaoundere, Cameroon
  • Richard Tagne Simo Department of Biomedical Sciences, Faculty of Science, University of Ngaoundere, Ngaoundere, Cameroon
  • Franklin Danki Sillong Islamic clinic of Adamawa, Ngaoundere, Cameroon

DOI:

https://doi.org/10.6000/1929-2279.2018.07.02.2

Keywords:

Cancer, prostate, Cameroon, epidemiology.

Abstract

Introduction: The high mortality rate of prostate cancer in Cameroon, its high incidence, its prevalence, the lack of epidemiological data for the north which for the case is the poorest area of the country led us to conduct this study with for the purpose of presenting the epidemiological, clinical and para-clinical aspects, the cost and means of management with a view to setting up adequate management policies. Patients and Methods: We conducted a cross-sectional analytical study in the city of Ngaoundéré for a period of 5months. The data were obtained after a survey of patients and collection of results from the pathology registry of the Islamic clinic of Adamawa three months before the start of our study. Results: The prevalence and incidence of prostate cancer were 28.7% and 24.32%, respectively. The average age of prostate cancer patients was 66.5 years. Gleason scores were less than 6 in 44.44% of cases. Risk factors related to familial cancer cases were difficult to determine. The symptoms were dominated in patients by urinary retention associated with polyuria, dysuria and pollakiuria. The means and costs of care were scalable depending on the difficulty of achieving the technique.Conclusion: Prostate cancer remains a real health problem in the north because of its incidence and high prevalence and requires the implementation of a government policy of care.

References

Cameroon Country Report.pdf. [en ligne]. [Consulté le 20 décembre 2017]. Disponible à l’adresse: https://www.laurea. fi/en/document/Documents/Cameroon%20Country%20Report.pdf

Final Data-Cameroon.pdf. [en ligne]. [Consulté le 20 décembre 2017]. Disponible à l’adresse: https://education-resources.wikispaces.com/file/view/Final%20Data-Cameroon.pdf/220373566/Final%20Data-Cameroon.pdf

Quatrième Enquête Camerounaise Auprès des Ménages (ECAM 4): Tendance, profil et déterminants de la pauvreté au Cameroun entre 2001-2014. Institut national de la statistique, déc-2015.

Nkwenkeu SF. Evaluation des politiques publiques de santé: une analyse économique appliquée au Cameroun 2014.

Ferlay J. Globocan 2008, cancer incidence and mortality worldwide: IARC Cancer Base 2010; No. 10, http://globocan.iarc. fr

Orock E, Ndom P, et Dah A. Current cancer incidence and trends in Yaounde, Cameroon. Oncology, Gastroenterology and Hepatology Reports 2012; 1(1): 58-63. https://doi.org/10.5530/ogh.2012.1.14

profil des pays pour le cancer, organisation mondiale de la santé, 2014.

NIS_Améliorer l’accès aux chimiothérapies anticancéreuses au Cameroun.pdf.

Startsev VY, Pouline I, Gorelov S, Merkulova R. Could the sextant prostate biopsy be replaced by transurethral resection? Archivio Italiano di Urologia Andrologia 2005; 77(4): 194.

Konan P, Gowe E, Dékou A. Cancer métastatique de la prostate dans le service d’urologie du CHU de Cocody. Revue Africaine d’Urologie et d’Andrologie 2015; 1(4).

Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of Transurethral Resection of the Prostate (TURP)—Incidence, Management, and Prevention. European Urology 2006; 50(5): 969-980. https://doi.org/10.1016/j.eururo.2005.12.042

Mathieu R, Tibari Y, Verhoe G, Vincendeau S, Manunta A, Rioux-Leclercq N, et Bensalah K. Étude comparée des résultats histologiques de résection et de biopsies de prostate. Progrès en urologie 2014; 24(6): 374-378. https://doi.org/10.1016/j.purol.2013.10.002

Amégbor K, Seddoh TY, Tengué K, Songne-Gnamkoulamba B, Napo-Koura G, James K. Épidémiologie et histopronostic du cancer de la prostate au Togo: à propos de 202cas diagnostiqués au laboratoire d’anatomie pathologique du CHU Tokoin de Lomé. Progrès en urologie 2009; 19(2): 112-115. https://doi.org/10.1016/j.purol.2008.10.008

Garba SM, Zaki HM, ArfaouI AH, Soulaymani A, Nouhou H, et Quyou A. Épidémiologie des cancers au Niger, 1992 à 2009. Bulletin du cancer 2013; 100(2): 127-133.

Salah R, Harir N, Zeggai N, Sellam F, Merabent N, Moullessehoul S, et Bedjaoui M. Cancers urologiques en Algérie : profil histo-épidémiologique à propos de 348 cas. Urological cancers in Algeria: Histo-epidemiological profile of 348 cases. Journal Africain du Cancer 2015; 7(2): 126-131. https://doi.org/10.1007/s12558-014-0342-9

Ammani A. Profil épidémiologique du cancer de la prostate dans le service d’urologie de l’hôpital Mohammed V de Rabat. Journal Marocain d’Urologie 2007; 1(5): 11-14.

Amégbor K, Seddoh TY, Tengué K, Songne-Gnamkoulamba B, Napo-Koura G, James K. Épidémiologie et histopronostic du cancer de la prostate au Togo: à propos de 202cas diagnostiqués au laboratoire d’anatomie pathologique du CHU Tokoin de Lomé. Progrès en urologie 2009; 19(2): 112-115. https://doi.org/10.1016/j.purol.2008.10.008

Bahloul A, Charfi S, Franck F, Jung JL. Carcinome épidermoïde Primitif de la Prostate: A propos d’un cas et revue de la littérature. African Journal of Urology 2016; 22(4): 235-239. https://doi.org/10.1016/j.afju.2015.07.006

Sow M, Essame Oyono J, Nkegoum B, Mbakop A. La biopsie de la prostate: Indications, technique et résultats: A propos de 161 cas colligés au Service d’Urologie de l’Hôpital Central de Yaoundé. Médecine d’Afrique noire 2001; 48(4): 159-162.

Cicione A, De Nunzio C, Tubaro A, Cantiello F, Manno S, Oliveira C, Lima E, et Damiano R. Metabolic syndrome diagnosis and widespread high grade prostatic intraepithelial neoplasia significantly increase prostate cancer risk: results from a multicenter biopsy study. Biomedical Sciences Cancer 2016; 16(1): 59. https://doi.org/10.1186/s12885-016-2085-8

Pacelli A, Bostwick DG. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens. Urology 1997; 50(3): 355-359. https://doi.org/10.1016/S0090-4295(97)00249-5

Fournier G, Valeri A, Mangin P, Cussenot O. Cancer de la prostate. Diagnostic et bilan d’extension. présenté à Annales d’urologie 2004; 38: 207-224. https://doi.org/10.1016/j.anuro.2004.06.003

Mbakop A, Angwafo F, Tsingain K. Tumeurs de la prostate (adénomes, adénocarcinomes) et obésité en milieu camerounais. Bulletin du Cancer 1995; 82(5): 384-385.

Molinier EB, Dervaux L, Soulié B, Latorzeff M, Bachaud I, Villers J-M, Elias A, et Grosclaude P. Coût et efficacité des stratégies de prise en charge thérapeutiques du cancer localisé de prostate: étude de faisabilité en population générale. Progrès en Urologie 2003; 13: 618-23.

Haillot O, Villers A, Soulie M, Baron J-C, Bensadoun H. Dépistage du cancer de la prostate (IV). Approche économique: les coûts des tests de dépistage et des traitements. Commentaire. Progrès en urologie 1998; 8(4): 517-523.

Ploussard G, Bruyère F, Culine S, De La Taille A, Hennequin C, Oudard S, Pfister CV, Ravery, et Salomon L. Modalités de castration dans la prise en charge du cancer de la prostate: sont-elles toutes équivalentes? Progrès en Urologie 2016; 26(5): 319-328. https://doi.org/10.1016/j.purol.2016.02.010

Downloads

Published

2021-08-23

How to Cite

Herve Kada Pabame, Armel Herve Nwabo Kamdje, Richard Tagne Simo, & Franklin Danki Sillong. (2021). Study of the Prevalence and the Incidence of the Prostate Cancer in the North-Cameroon: Means and Costs of Management. Journal of Cancer Research Updates, 7(2), 41–48. https://doi.org/10.6000/1929-2279.2018.07.02.2

Issue

Section

Articles